These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2110959)

  • 1. An aid to the selection of chemotherapy regimens for oral cavity carcinomas. Early results of a study of 5-year survival based on antioncogram selection of anti-cancer drugs.
    Metelmann HR; Wolff K; Jonas S; Schlesinger S; Marin A
    Int J Oral Maxillofac Surg; 1990 Feb; 19(1):44-6. PubMed ID: 2110959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment results with antioncograph-oriented cytostatic combinations in patients with carcinomas of the oral cavity].
    Metelmann HR; Schlesinger S
    Dtsch Z Mund Kiefer Gesichtschir; 1988; 12(4):307-9. PubMed ID: 3240612
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
    Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
    J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary cytostatic therapy of progressive squamous cell carcinoma of the oral cavity].
    Bienengräber V
    Arch Geschwulstforsch; 1986; 56(5):353-6. PubMed ID: 2429630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
    Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
    J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
    Pederson AW; Salama JK; Witt ME; Stenson KM; Blair EA; Vokes EE; Haraf DJ
    Am J Clin Oncol; 2011 Aug; 34(4):356-61. PubMed ID: 21633289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental chemotherapy using transplantable human oral cancer in nude mice by SRC assay].
    Mochizuki A
    Fukuoka Shika Daigaku Gakkai Zasshi; 1989; 16(3):472-84. PubMed ID: 2486705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
    Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
    Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
    Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
    Licitra L; Grandi C; Guzzo M; Mariani L; Lo Vullo S; Valvo F; Quattrone P; Valagussa P; Bonadonna G; Molinari R; Cantù G
    J Clin Oncol; 2003 Jan; 21(2):327-33. PubMed ID: 12525526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies of preoperative tumor reductive chemotherapy with PPV regimen in the treatment of oral squamous cell carcinoma].
    Jin Y; Shen Y; Ma G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 May; 30(3):166-8. PubMed ID: 7489653
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: does it make a difference?
    Patil VM; Noronha V; Joshi A; Muddu VK; Gulia S; Bhosale B; Arya S; Juvekar S; Chatturvedi P; Chaukar DA; Pai P; D'cruz A; Prabhash K
    Indian J Cancer; 2013; 50(1):1-8. PubMed ID: 23713035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of quinocarmycin against carcinoma of the lung in human tumor clonogenic assay.
    Chiang CD; Kanzawa F; Matsushima Y; Nakano H; Nakagawa K; Takahashi H; Terada M; Morinaga S; Tsuchiya R; Sasaki Y
    J Pharmacobiodyn; 1987 Sep; 10(9):431-5. PubMed ID: 3437383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay].
    Inoue K; Mukaiyama T; Yamazaki H; Horikoshi N; Ogawa M; Kobayashi T; Aiba K; Kuraishi Y
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):356-61. PubMed ID: 3080968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate.
    Hill BT; Price LA
    Am J Clin Oncol; 1994 Feb; 17(1):1-5. PubMed ID: 8310999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
    Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
    Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonogenic assays in the evaluation of antitumor chemotherapy].
    Aapro MS
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1266-9. PubMed ID: 3313688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumor clonogenic assay in patients with unknown primary carcinomas.
    Greenberg BR; Salmon SE
    J Clin Oncol; 1984 Jan; 2(1):46-50. PubMed ID: 6699658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of the growth capacity of cell explants from carcinomas of the mouth in an anti-oncogram. A contribution toward the planning of cytostatic chemotherapy].
    Metelmann HR; Sänger E; Dreweck C; Schlesinger S; Bier J
    Dtsch Z Mund Kiefer Gesichtschir; 1986; 10(5):345-53. PubMed ID: 3482035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.